Company: BGLC
Filing Date: 2025-02-27
Form Type: DEF 14A
Source: 0001477932-25-001335
Chunk: 30

Company: BioNexus Gene Lab Corp
Filing Date: 2025-02-27
Form: DEF 14A
Chunk 30
---
 a copy of these reports, including the financial statements and financial statement schedules, without charge, by writing to Investor Relations at our principal executive offices located at Unit A-28-7, Tower A, Menara UOA Bangsar, No.5 Jln Bangsar Utama 1, 59000 Kuala Lumpur. We will furnish upon request any exhibits to the Form 10-K upon the payment by the requesting stockholder of our reasonable expenses in furnishing such exhibits. Additionally these reports, proxy statements and other information regarding the Company, are also available on our website at or the Securities and Exchange Commission’s public website at .

All stockholders are urged to vote by following the instructions on the Notice or, if printed proxy materials were received, by following the instructions provided with printed proxy materials.

| 20 |

ANNEX A

<div align='center'>Form of Charter Amendment

ARTICLES OF AMENDMENT

TO THE

ARTICLES OF INCORPORATION

OF

BIONEXUS GENE LAB CORP</div>

BioNexus Gene Lab Corp. (the “Corporation”), a corporation organized and existing under and by virtue of the Wyoming Business Corporation Act (the “WBCA”), does hereby certify:

Pursuant to Section 17-16-1003 of the WBCA, this Articles of Amendment to the Articles of Incorporation (this “Certificate of Amendment”) amends the provisions of the Corporation’s Articles of Incorporation, as amended (the “Charter”).

This Articles of Amendment has been approved and duly adopted by the Corporation’s Board of Directors and stockholders in accordance with the provisions of Section 17-16-1003 of the WBCA.

Upon this Articles of Amendment becoming effective, the Charter is hereby amended as follows:

Article V of the Corporation’s Charter is hereby amended to read in its entirety as follows:

In conjunction with this Articles of Amendment to the Articles of Incorporation, the shares of Common

Stock issued and outstanding immediately prior to the filing of this Articles of Amendment, every [*] shares of Common Stock issued and outstanding or held by the Corporation as treasury shares as of the filing of these Articles of Amendment shall automatically, and without action on the part of the stockholders, be combined, reclassified and changed into one (1) validly issued, fully paid and non-assessable share of Common Stock, in all instances without effecting a change to the par value per share of Common Stock, and subject to the treatment of fractional interests as described